| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | US6723340 Optimal polymer mixtures for gastric retentive tablets |
| 04/20/2004 | US6723327 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 04/20/2004 | US6723317 Binds to amino acid sequence 1,2 or 4; identification of human papillomavirus (hpv) 16 viral structures |
| 04/20/2004 | US6723316 Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth |
| 04/20/2004 | CA2125408C Drug formulations for parenteral use |
| 04/20/2004 | CA2102778C Novel compositions based on taxane class derivatives |
| 04/16/2004 | CA2443585A1 New derivatives of (3,4-a:3,4-c) carbazole, their preparation process, and pharmaceutical compositions that contain them |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004031775A2 Method for treating or preventing metastasis of colorectal cancers |
| 04/15/2004 | WO2004031774A2 Method for treating or preventing metastasis of colorectal cancers |
| 04/15/2004 | WO2004031413A2 Method for diagnosing non-small cell lung cancers |
| 04/15/2004 | WO2004031380A1 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 04/15/2004 | WO2004031236A2 Therapeutic uspa1-derived peptides |
| 04/15/2004 | WO2004031221A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031220A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031219A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031218A1 Tumor targeting agents and uses thereof |
| 04/15/2004 | WO2004031177A1 2-aminobenzimidazole derivative |
| 04/15/2004 | WO2004031158A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 04/15/2004 | WO2004031130A1 Use of cyclic depsipeptide as a chemotherapeutic agent against cancer |
| 04/15/2004 | WO2004031125A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 04/15/2004 | WO2004031122A1 Novel curcumin/tetrahydrocurcumin derivatives for using in cosmetics, pharmaceuticals and for nutrition |
| 04/15/2004 | WO2004030697A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 04/15/2004 | WO2004030691A1 Sustained release preparation containing nk4 |
| 04/15/2004 | WO2004030688A1 Novel method of controlling apoptosis by controlling interaction between proteins and drug using the same |
| 04/15/2004 | WO2004030671A2 Use of 4-amino-quinazolines as anti cancer agents |
| 04/15/2004 | WO2004030662A1 Combination chemotherapy compositions and methods |
| 04/15/2004 | WO2004030660A2 Compositions for treatment of prostate and other cancers |
| 04/15/2004 | WO2004030440A2 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 04/15/2004 | WO2004019991A3 Scatter factor/hepatocyte growth factor antagonist nk4 for the treatment of glioma |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004011486A3 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 04/15/2004 | WO2004009558A3 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
| 04/15/2004 | WO2004006850A3 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 04/15/2004 | WO2004003545A9 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 04/15/2004 | WO2004003209A3 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 04/15/2004 | WO2004002477A8 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | WO2003103588A3 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 04/15/2004 | WO2003099859A3 Novel use of adenoviruses and nucleic acids coding therefor |
| 04/15/2004 | WO2003085134A3 Methods of diagnosing and treating colorectal cancer |
| 04/15/2004 | WO2003070752A3 Mhc-peptide complex binding ligands |
| 04/15/2004 | WO2003059951A3 Novel anti-igf-ir antibodies and uses thereof |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003049717A3 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases |
| 04/15/2004 | WO2003045324A3 14-methyl-epothilones |
| 04/15/2004 | WO2003043580A3 Methods for identifying and validating potential drug targets |
| 04/15/2004 | WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/15/2004 | WO2003026574A3 Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 04/15/2004 | WO2003022844A9 Synthesis of epothilones intermediates thereto and analogues thereof |
| 04/15/2004 | WO2003004604A9 Phage displayed pdz domain ligands |
| 04/15/2004 | WO2003002722A9 T cell regulatory genes and methods of use thereof |
| 04/15/2004 | WO2002100354B1 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 04/15/2004 | WO2002081703A9 Mitogenic oxygenase regulators |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2002055706A3 Asip-related proteins |
| 04/15/2004 | WO2002039999B1 Use of suramine, l-histidine, quisqualic acid or d-cycloserine for angiogenesis inhibition |
| 04/15/2004 | WO2002009690A8 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 04/15/2004 | WO2002000611A9 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/15/2004 | WO2002000227A8 Use of lanthanum compounds for the treatment of bone diseases |
| 04/15/2004 | WO2001019852A8 Methods of peptide preparation |
| 04/15/2004 | US20040073958 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 04/15/2004 | US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040073007 Antiangiogenic peptides |
| 04/15/2004 | US20040072998 Comprises nucleotide sequences coding transient receptor proteins (TRP) for diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072993 Identifying modulator of chimeric chaperone protein for treatment and diagnosis of immune, cell proliferative and infectious disorders |
| 04/15/2004 | US20040072915 Novel medicines based on sesquiterpene mixtures |
| 04/15/2004 | US20040072914 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 04/15/2004 | US20040072913 Skin disorders; induce cell differentiation; using plant extract |
| 04/15/2004 | US20040072892 Dipeptidyl aminopeptidase inhibitors; kidney and liver disorders; autoimmune diseases; antiarthritic agents; psoriasis; anticancer agents |
| 04/15/2004 | US20040072890 Anticancer agents |
| 04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072876 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 04/15/2004 | US20040072870 Anticancer agents |
| 04/15/2004 | US20040072850 Caspase inhibitors and uses thereof |
| 04/15/2004 | US20040072846 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072804 Anticancer agents; skin disorders; bone disorders |
| 04/15/2004 | US20040072803 Novel compounds for modulating cell proliferation |
| 04/15/2004 | US20040072795 Complex of Dna and lipid with detectable label; accuracy positioning; anticancer agents, antiinflammatory agents |
| 04/15/2004 | US20040072791 Method for producing pectin hydrolysis products |
| 04/15/2004 | US20040072780 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 04/15/2004 | US20040072779 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 04/15/2004 | US20040072778 Prognosis of neuroblastoma; antisense nucleic acids for malignant tumors |
| 04/15/2004 | US20040072776 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072766 Bioassay for screening an inhibitor or activator of phosphatidylinositol 3-kinase, finding immunostimulants, or immunosuppressants |
| 04/15/2004 | US20040072762 Diazocine derivatives and their use as tryptase inhibitors |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072758 Contulakin-G, analogs thereof and uses therefor |
| 04/15/2004 | US20040072751 A kits for use in drug screening antagonists, agonists; a recombinant vector polynucleotide, cell culturing, an antibody used for diagnostic, for adjusting the expression of the G protein-coupled receptor protein |
| 04/15/2004 | US20040072738 Analogues of thiocoraline and be-22179 |
| 04/15/2004 | US20040072735 Administering suberoylanilide hydroxamic acid (SAHA) to inhibit histone deacetylase (HDAC) to a patient for cancer cell growth arrest and/or apoptosis of neoplastic cells |
| 04/15/2004 | US20040072340 Use of peptide vectors to improve the immune response to antigens |